Aims: The aim of this study was to synthesise and evaluate the effectiveness of mobile phone-based self-management interventions for medication adherence and change in blood pressure in patients with coronary heart disease. Methods: Relevant randomised controlled trials evaluating mobile phone-based self-management interventions for medication adherence and/or change in blood pressure in coronary heart disease patients were identified by searching six electronic databases (PubMed, Cochrane, CINAHL, ProQuest, Scopus and EMBASE) from January 2008 to January 2019. The trials were screened, data were extracted and quality was assessed by two independent reviewers. Metaanalyses were performed for different outcomes while narrative syntheses were conducted for studies that could not be pooled or when there was the presence of high heterogeneity.
Introduction
Coronary heart disease (CHD) is a major cause of death and morbidity as well as impaired quality of life. 1 The main risk factors for CHD -obesity and sedentary lifestyle coupled with high blood pressure (BP), smoking and high blood cholesterol -are amenable to behavioural change interventions through the use of mobile phone text messaging 2 and applications. 3 Medication adherence presents a particular challenge as non-adherence in CHD patients is associated with poor self-management leading to poor clinical outcomes, including rehospitalisation, subsequent myocardial infarction and increased mortality. 4, 5 High BP is strongly associated with the risk of CHD events 6 and secondary prevention efforts are focused on achieving good BP control: defined as systolic BP less than 120 mmHg and diastolic BP less than 80 mmHg. 7 Maintaining optimal BP is crucial in reducing the risk of subsequent cardiovascular complications. 6 Lately, mobile phone-based technologies have been increasingly used in promoting physical activity and lifestyle modification among patients with CHD. 8 According to the International Telecommunication Union, 9 69% of the world's adult population has mobile broadband subscriptions. Mobile phone-based technologies such as text messaging and applications are ubiquitous, offering promising potential to improve an individual's health by helping them with self-management and healthy behaviour modifications. 10 Due to accessibility and ease of use, mobile phone technology allows real-time information to be retrieved conveniently for relevant and personalised decisions to be made for efficient behaviour change support. 3, 11 For instance, patients may input their BP readings and exercise frequencies into a mobile phone-based application, permitting healthcare providers almost instant access to these data and the ability to offer personalised advice as required. In addition, automated medication reminders or motivational and educational messages can be sent to patients to enhance knowledge and adherence. 12 Thus, mobile phone-based technologies for CHD patients help increase access to pertinent information to enhance knowledge of their disease. 8 This is likely to help patients develop self-efficacy, encourage behavioural change and improve adherence. 13 Of recent systematic reviews of mobile phone-based interventions for CHD patients, [14] [15] [16] [17] only a narrative synthesis was reported regarding medication adherence. One of these reviews 15 reported a meta-analysis of mobile health interventions on the combination of pharmacological and non-pharmacological adherence. Hence, any change in adherence scores may not necessarily be due to pharmacological (medication) adherence alone. Two reviews 15,17 did not evaluate the risk of bias of each included study which is crucial in providing an indication of the quality of available evidence. Moreover, one review by Yousuf et al. 17 only conducted a systematic search in PubMed which may introduce database bias. In addition, none of these reviews reported a meta-analysis on BP outcomes. [14] [15] [16] [17] Therefore, the effectiveness of mobile phonebased technologies on medication adherence and change in BP remains unclear. As medication adherence and change in BP are crucial secondary prevention measures, the current review aims to synthesise and evaluate the effectiveness of mobile phone-based self-management interventions on medication adherence and change in BP in patients with CHD.
Methods
The preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist was adopted as a guideline to ensure transparency, accuracy and comprehensiveness of the dissemination of data in this review. 18 
Search strategy
Relevant randomised controlled trials were identified by searching PubMed, Embase, Cochrane Central Register of Controlled Trials (Cochrane), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus and ProQuest databases from January 2008 to January 2019. The search terms and strategy are provided in Supplementary Appendix 1.
In addition, searches of grey literature such as ongoing trials with outcomes from the Clinical Trials Registry (www.clinicaltrials.gov) and New York Academy of Medicine grey literature report (https://nyam.org/) were performed using keywords. A manual screening of the reference list in eligible studies and relevant systematic reviews of the topic was also done to identify additional relevant trials that were not retrieved through database searching.
Study selection
Studies that met the following eligibility criteria were included: (a) designed as a randomised controlled trial (RCT) or a cluster RCT; (b) published in English in the last 11 years from January 2008 to January 2019 to include the most recent research (c) population included adults (aged≥ 18 years) who were clinically diagnosed with CHD; (d) used mobile phone-based self-management interventions with either text messaging or patient-directed applications that provided education or self-monitoring functions; (e) reported medication adherence and/or BP (systolic or diastolic) outcomes; and (f) had a comparator that did not use a mobile health intervention, including but not limited to usual care or waitlist.
We excluded interventions that were solely based on phone calls or computer use. We also excluded articles that were abstracts only, conference papers, discussion papers or letters.
The articles retrieved from the search were imported into a reference manager, EndNote Software Version X8 (Thomson Reuters, New York, USA). Duplicates were removed using the software and manually by hand. Firstly, titles and abstracts of the studies were screened independently by two reviewers (YSS and YJ) to identify potential trials to be included in this review. Studies with titles and abstracts deemed inappropriate were removed. If there were any uncertainties, over caution was imposed and a full-text version of the article was obtained for thorough appraisal. Next, full-text review of the remaining articles that fulfilled the eligibility criteria was included if there was unanimous agreement between the two reviewers. In the case of differing opinions regarding the inclusion or exclusion of a study, the study was reassessed again and a discussion was held until consensus was attained. A third reviewer (WW) was consulted for any unresolved disputes.
Data extraction
All outcome data were extracted independently by YSS and YJ using a standardised data extraction form modified accordingly from the Cochrane handbook for systematic reviews of intervention. 19 In the case of incomplete relevant data for extraction, the respective study authors were contacted for information. The extracted data were then computed into RevMan software by YSS, while YJ ensured that the data computed were accurate.
Quality appraisal
Each study was evaluated for the risk of bias by YSS and YJ independently using the risk of bias tool in the Cochrane handbook for systematic reviews of interventions. 19 Disparities among the two reviewers were settled through discussion and consultation with WW. Five biases (i.e. selection bias, performance bias, detection bias, attrition bias and reporting bias) were assessed and categorised as 'low risk', 'high risk' or 'unclear risk' for each study.
Data synthesis and analysis
RevMan 5.3 software was used to synthesise the data. 19 The outcomes of the included studies were presented as continuous data and analysed using the inverse variance approach by combining the mean difference of individual studies. When the outcome (medication adherence) was reported using different measurement scales, the standardised mean difference of individual studies was combined. When a study had multiple intervention arms using a shared control group, the sample size, mean and standard deviations of the relevant experimental intervention arms were combined into a single intervention arm based on the method recommended by the Cochrane handbook of systematic reviews of interventions. The amplitude of the pooled treatment effect size was evaluated using Cohen's d whereby d<0.2 indicates negligible effect, 0.2⩽d<0.5 indicates small effect, 0.5⩽d<0.8 indicates medium effect and d⩾0.8 indicates large effect. 20 The overall effect was assessed by the Z-statistic. The significant level was set at P<0.05. 19 Given the differences in the behaviour change interventions, patient populations, measures and outcome assessment time points, it would be likely that the true effect size varied across the studies. Therefore, a random-effects model was used for all meta-analyses to estimate the means of these effects. 21 Heterogeneity was estimated using the chi-squared test and I 2 test. For heterogeneity to be statistically significant, the P value was set at less than 0.10 and the degree of variability was determined using I 2 values whereby 0% to 40% indicates unimportant heterogeneity, 30% to 60% moderate heterogeneity, 50% to 90% substantial heterogeneity and 75% to 100% considerable heterogeneity. 19 In the case of considerable and significant heterogeneity whereby I 2 was more than 50% and the P value was less than 0.10, a narrative and qualitative summary was performed. 22 Figure 1 illustrates the PRISMA flow diagram in the systematic search process. A total of 2306 articles was retrieved from the six electronic databases, and no studies were identified through grey literature searching or from reference lists. Some 957 articles were duplicates and 30 were published before the year 2008, leaving 1319 articles for screening, of which 1152 were excluded based on title and abstract.
Results

Study selection
The remaining 167 articles were then assessed in fulltext independently against the eligibility criteria by YSS and YJ and 152 were excluded (Figure 1 ), leaving 15 trials deemed eligible for review. These 15 trials were evaluated independently for quality by both reviewers. Four had insufficient information for meta-analysis [23] [24] [25] [26] and the study authors were contacted, but there was no response from any of them. Hence, these four trials [23] [24] [25] [26] are presented in narrative form. The remaining 11 trials [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] were incorporated in various meta-analyses according to their reported outcomes.
Description of studies
The summary of characteristics of the 15 trials can be found in Supplementary Appendix 2: 14 (93.3%) of which were individualised RCTs [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] and one (6.7%) a cluster RCT. 37 From the 15 trials, 19 mobile phone-based selfmanagement intervention arms were reported. Three trials 26, 33, 35 compared two smartphone-based intervention arms to a control group, although only one 35 combined the results of the two intervention arms into a single value instead of separate ones. One trial 24 included four different groups of participants and two different sets of intervention against control results: medication adherence intervention group versus medication adherence control group and exercise adherence intervention group versus exercise adherence control group.
Description of participants
The sample size across all 15 trials (total n=2978; men n=2326, women n=652) ranged from 28 to 710 participants. The mean age of all participants ranged from 53.7 to 75.3 years, although one trial 32 did not report these. Five trials had an age inclusion criteria of 18 years or older, [29] [30] [31] [32] 35 one of 21 years or older, 33 one of 65 years or older 37 and one of 75 years or younger; 28 the remaining seven trials did not specify an age limit. [23] [24] [25] [26] [27] 34, 36 Different definitions of CHD were used in the trials: acute coronary syndrome (n=2, 13.3%), 23, 27 chronic stable angina (n=1, 6.7%), 26 post-myocardial infarction (n=3, 20%), 24, 30, 36 revascularisation (n=8, 53.3%) 25, 28, 29, 31, [33] [34] [35] 37 and one (6.7%) with no definition specified. 32 Only one trial 31 clearly indicated that participants should be diagnosed with CHD for at least 6 months.
All trials included participants who could speak, write and understand English or the native language(s) used locally. In addition, all participants eligible for inclusion were required to know how to use at least the text messaging function on mobile phones. Five trials did not require participants to own a mobile phone as it was provided by the researchers, 27, 28, 31, 34, 36 while the other 10 trials required participants to own one personally. [23] [24] [25] [26] 29, 30, 32, 33, 35, 37 
Description of interventions
The description of interventions has been categorised into mode of delivery, frequency and duration of interventions and intervention components (education, reminders, selfmonitoring and feedback) as summarised in Supplementry Appendices 2, 3 and 4.
Quality appraisal
The summary for risk of bias is shown in Figure 2 . Ten trials (66.7%) were classified as low risk of selection bias for random sequence generation. [24] [25] [26] 28, 29, 31, [32] [33] [34] [35] [36] Four trials (26.7%) were rated as low risk of selection bias for allocation concealment. 31, [34] [35] [36] No trial mentioned blinding of participants and personnel, which may be due to the intervention nature whereby blinding of both parties was not easy to establish and maintain. Five trials (33.3%) reported blinding of outcome assessment 27, 29, 31, 37 and one (6.7%) attrition bias. 37 One trial (6.7%) was identified as high risk of selection bias due to its cluster RCT design whereby participants were recruited into the trial after the cluster had been randomly assigned. 37 Four trials (26.7%) were rated as unclear risk of selection bias due to insufficient information provided about the randomisation procedure. 23, 25, 27, 30 
Effectiveness of mobile phone-based selfmanagement interventions on medication adherence
A meta-analysis was performed on four trials including five arms that reported post-intervention scores of medication adherence among participants (n=612). The combined intervention effect was in favour of the intervention group, but the effect was not statistically significant (d=0.72; 95% confidence interval (CI) -0.32 to 1.75; P=0.17) (Figure 3 ). The heterogeneity was high and significant (I 2 =97%; P<0.00001).
Due to the presence of considerable heterogeneity in the pooled meta-analysis, narrative synthesis was done. On a closer look, only three out of the four trials reported a standardised mean difference that favours the intervention group as indicated by the significant improvement in medication adherence among the experimental groups. 34, 35, 37 In particular, Lin et al. 37 reported a much greater mean difference than the other two studies, which may have contributed to the considerable heterogeneity in the current meta-analysis. On the other hand, Park et al. 33 reported no significant improvements in both intervention arms regarding medication adherence scores after 30 days.
Five other studies also reported the outcome of medication adherence but were not included in the meta-analysis because mean and standard deviation values were not reported. [23] [24] [25] [26] 32 As such, we were not able to pool the data from these studies. [23] [24] [25] [26] 32 Among the five studies, three measured medication adherence by number of events and found significant improvements in the experimental groups. 23, 24, 25 One study reported insignificant but better medication adherence in the experimental group. 32 Another study reported medication adherence based on various demographics, though only education level and disease history were found to have a significant correlation to medication adherence. 26 
Effectiveness of mobile phone-based selfmanagement interventions on change in systolic BP
A meta-analysis was performed on the eight trials that reported post-intervention levels of systolic BP among participants (n=1417). The pooled intervention effect in systolic BP was in favour of the intervention group, but the effect was not statistically significant (combined mean difference of −1.08 (95% CI −5.51 to 3.35; P=0.63) (Figure 4) . The heterogeneity was substantial and significant (I 2 =77%; P⩽0.0001).
Due to the presence of considerable heterogeneity in the pooled meta-analysis, a narrative synthesis was performed to compare different delivery modes of interventions (SMS n=3, mobile phone-based applications n=4, SMS plus smartphone applications n=1). Among the three studies 27, 29, 34 using SMS interventions, two studies 27, 29 reported significant improvements in the change of systolic BP postintervention. Pfaeffli et al., 34 however, reported that there were no differences in the change of systolic BP in either the control or experimental groups. All four studies that utilised only mobile phone-based application interventions reported that the changes in systolic BP were no significant differences between the control and experimental group. 28, 31, 32, 35 The only study that used SMS plus smartphone application intervention also reported no significant difference in the change of systolic BP between the experimental and control groups. 36 One trial was not included in the meta-analysis as systolic BP values were not reported in the mean and standard deviation. 30 
Effectiveness of mobile phone-based selfmanagement interventions on change in diastolic BP
A meta-analysis was performed on the eight trials that reported post-intervention levels of change in diastolic BP among participants (n=1417). The interventions were associated with a change in diastolic BP, and the effect was statistically significant (d=−1.99; 95% CI −3.20 to −0.78; P=0.001) ( Figure 5 ). The heterogeneity was low and insignificant (I 2 =12%; P=0.34).
Discussion
This review of 15 RCTs (n=2978) of mobile phone-based self-management interventions for CHD patients found they were associated, although not statically significantly, with improved medication adherence and statistically significantly with change in diastolic, but not systolic BP. However, there was great variation among the trials with intervention mode being smartphone applications, SMS or both, duration ranging from one to 18 months, frequency varying from three times a week to four times a month and content using different combinations of self-management components, such as feedback, reminders, education and self-monitoring.
The statistically non-significant association with improvements in medication adherence [33] [34] [35] 37 may be partly due to insufficient sample sizes. In addition, a high degree of heterogeneity was found among the trials, likely due to the different measurement tools, combinations of intervention components and delivery modes. This finding is consistent with another review which reported high heterogeneity in medication adherence. 17 The finding of a medium effect size for mobile phonebased self-management interventions on medication adherence is consistent with narrative reviews. 16, 17, 19 The incorporation of self-management components in mobile phone-based interventions, such as medication reminders, may help boost an individual's confidence in their self-care activities. [38] [39] [40] A recent trial 35 found that the provision of daily medication reminders to patients helps address forgetfulness, a common unintentional reason for non-adherence.
The finding that mobile phone-based self-management interventions are associated with a statistically significant reduction in diastolic BP but not systolic BP is novel and intriguing but the reasons are unclear, thus warranting further exploration. Other reviews evaluating the effectiveness of telehealth interventions on BP outcomes found no effect on systolic or diastolic BP. [41] [42] [43] A recent review 44 of medication adherence behaviour change interventions on BP outcomes found that they were effective in decreasing systolic and diastolic BP, but the effect size was modest. These findings reflect the difficulty in changing adherence behaviour to control BP, as well as the other health behaviours that are associated with health outcomes. As authors of the review 44 noted, while most interventions focus on knowledge and beliefs, these may not be adequate to sustain behavioural change. Their exploratory moderator analysis found that habit-focused interventions, which examine the participant's routines and link their medication administration to existing habitual behaviours, might be more effective than the other interventions. 44 Consideration of this in future mobile phone-based self-management interventions may prove fruitful.
The high levels of patient satisfaction and interest among patients using mobile phone-based technologies for the self-management of CHD 45 present an array of opportunities to evaluate and determine the delivery mode, content, duration and frequency likely to be most effective in medication adherence and BP control as well as other cardiovascular outcomes.
Limitations
The main limitation of this review was the presence of high heterogeneity in medication adherence and change in systolic BP outcomes due to variances in study designs, samples and interventions. Such inherent heterogeneity is expected with behaviour change interventions, but complicates efforts to synthesise the results of intervention studies. In addition, most trials revealed selection and performance bias, whereby allocation concealment and blinding of participants and personnel were not carried out. Hence, the meta-analyses results may have been influenced by the low quality of included trials. 20 Furthermore, only English language articles were included, which may introduce inherent bias. A comprehensive search of multiple databases including other languages might mitigate this bias. Finally, some relevant studies were not included due to a lack of reported data for calculating effect sizes.
Conclusion
Mobile phone-based self-management interventions for CHD patients were associated with improved medication adherence, despite a lack of statistical significance. Moreover, such interventions were associated with a statistically significant reduction in diastolic BP but not systolic BP. Despite a high degree of heterogeneity among trials, the findings suggest that mobile phone-based selfmanagement interventions have the potential to improve health experiences and outcomes for CHD patients. With the rapid advancement in technologies, the growth of mobile phone usage globally and the numerous applications and functions available, choice is likely to be a major consideration.
Implications for practice
• • A high degree of heterogeneity was found in the mobile phone-based self-management interventions for patients with CHD. • • Mobile phone-based self-management interventions were associated with a reduction in diastolic blood pressure, but not systolic blood pressure • • An improvement in medication adherence was observed, though this was not statistically significance
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